AZD9773 Dose Escalation Study

PHASE2CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions
Severe Sepsis
Interventions
DRUG

AZD9773 (CytoFab)

intravenous infusions

OTHER

Placebo

Placebo

Trial Locations (26)

Unknown

Research Site, Birmingham

Research Site, Newark

Research Site, Bay Pines

Research Site, Miami

Research Site, Chicago

Research Site, Oak Park

Research Site, Peoria

Research Site, Indianapolis

Research Site, Iowa City

Research Site, Hazard

Research Site, Lexington

Research Site, Baltimore

Research Site, Kansas City

Research Site, Camden

Research Site, Newark

Research Site, Brooklyn

Research Site, New York

Research Site, Rochester

Research Site, Durham

Research Site, Greensboro

Research Site, Winston-Salem

Research Site, Columbus

Research Site, Oklahoma City

Research Site, Nashville

Research Site, Galveston

Research Site, Houston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY